caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1174519268

Melvin BreiteM.D.

Internal MedicineBayside, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 337008
Home health agency
CCN 337148
Home health agency
CCN 337290
Home health agency
CCN 330055
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
947
Unique beneficiaries
—
Total services
1,410
Distinct HCPCS
13
Medicare payment
$72K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).
REFERRAL NETWORK

Where Melvin Breite's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NEW YORK-PRESBYTERIAN-QUEENS174793
NORTH SHORE UNIVERSITY HOSPITAL2149
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
1330
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
RODGERS, WILLIAM176827
NEW YORK-PRESBYTERIAN-QUEENS67238
NEWYORK-PRESBYTERIAN-QUEENS2986
NORTH SHORE UNIVERSITY HOSPITAL1763
Lillian Graf
Dermatology · Bayside, NY
1326
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
1223
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,806
Beneficiaries
—
Total drug cost
$143K
Distinct drugs
68
Brand share
14.2%
Top prescribed drugs
Atorvastatin Calcium283 claims
Amlodipine Besylate232 claims
Levothyroxine Sodium137 claims
Rosuvastatin Calcium129 claims
Simvastatin116 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity